Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
7
|
| pubmed:dateCreated |
1991-7-18
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jul
|
| pubmed:issn |
0732-183X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
9
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1322-4
|
| pubmed:dateRevised |
2006-4-24
|
| pubmed:meshHeading |
pubmed-meshheading:2045874-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:2045874-Carcinoma,
pubmed-meshheading:2045874-Colorectal Neoplasms,
pubmed-meshheading:2045874-Fluorouracil,
pubmed-meshheading:2045874-Humans,
pubmed-meshheading:2045874-Leucovorin,
pubmed-meshheading:2045874-Methotrexate,
pubmed-meshheading:2045874-Prognosis
|
| pubmed:year |
1991
|
| pubmed:articleTitle |
What is the value of methotrexate in the treatment of advanced colorectal cancer?
|
| pubmed:publicationType |
Letter,
Comment
|